Hence, the combinatory evaluation of miR-4429 and CD274 bears great potential for assessing the clinical prognosis of ccRCC patients, suggesting a plausible regulatory mechanism for CF274 as an oncogene in ccRCC. This evidence concerns the gene CD274 and nonpapillary renal cell carcinoma.